{"id":"W2058211318","doi":"10.1016/j.euroneuro.2005.02.006","title":"Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","year":2005,"lang":"en","type":"article","venue":"European Neuropsychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; University of Toronto","funders":"AstraZeneca","keywords":"Quetiapine; Young Mania Rating Scale; Tolerability; Placebo; Mania; Haloperidol; Akathisia; Quetiapine Fumarate; Extrapyramidal symptoms; Psychology; Internal medicine; Anesthesia; Bipolar I disorder; Medicine; Adverse effect; Bipolar disorder; Psychiatry; Atypical antipsychotic; Antipsychotic; Lithium (medication); Schizophrenia (object-oriented programming)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001824681,0.002807784,0.007725896,0.00111588,0.0008280152,0.001153544,0.001606661,0.003672929,0.008248586],"category_scores_gemma":[0.002331573,0.00136989,0.002384932,0.0007986516,0.002086223,0.002033139,0.0005187943,0.003049697,0.001557391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009618872,"about_ca_system_score_gemma":0.001179225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002447428,"about_ca_topic_score_gemma":0.004797423,"domain_scores_codex":[0.9990966,0.0003803377,0.00007685173,0.0002149569,0.00007779605,0.0001534866],"domain_scores_gemma":[0.9991923,0.0002578031,0.0001266394,0.00007397432,0.00006030426,0.0002890381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9875917,0.002236316,0.0001057862,0.0006550087,0.0004469884,0.00003926375,0.00003998954,0.0001145099,0.001882253,0.00005532469,0.000416501,0.006416298],"study_design_scores_gemma":[0.9824948,0.01642026,0.0003872089,0.00001747622,0.0001854097,0.00001422365,0.000009431485,0.0001520464,0.000102871,0.00004486252,0.0001592152,0.00001226733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9697719,0.01269525,0.002096475,0.001245082,0.002152815,0.006999173,0.00168033,0.0006802278,0.002678785],"genre_scores_gemma":[0.9697562,0.008683168,0.003335362,0.001910807,0.001452206,0.00665661,0.001110952,0.00009314941,0.007001471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008248586,"threshold_uncertainty_score":0.02759433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04286451648119725,"score_gpt":0.3355459203576592,"score_spread":0.2926814038764619,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}